Inhibition of HER2 on tumor cells by molecularly imprinted nanoparticles
A particularly aggressive, metastasizing form of cancer, HER2-positive breast cancer, may be treated with nanoscopic particles "imprinted" with specific binding sites for the receptor molecule HER2. As reported by Chinese ...